Nadia Aspromonte to Purinergic P2Y Receptor Antagonists
                                
                                
                                    This is a "connection" page, showing publications Nadia Aspromonte has written about Purinergic P2Y Receptor Antagonists.
                                
                                
                                
                                    
                                        
                                                
    
        
        
        
            Connection Strength
            
                
            
            0.156
         
        
        
     
 
    
        
        - 
            [ANMCO/ANCE/ARCA/GICR-IACPR intersociety consensus document: long-term antiplatelet therapy in patients with coronary artery disease]. G Ital Cardiol (Rome). 2018 May; 19(5):263-331.
            
            
                Score: 0.156